RayzeBio Inc. Common Stoc... (RYZB)

NASDAQ: RYZB · Real-Time Price · USD

62.49

0.01 (0.02%)

At close: Feb 23, 2024, 9:00 PM

RayzeBio Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q4 2022	Q3 2022
Period Ending	Sep 30, 2023	Dec 31, 2022	Sep 30, 2022
Net Income	-18.19M	-14.7M	-20.45M
Depreciation & Amortization	500K	419K	404K
Stock-Based Compensation	2.56M	2.11M	1.45M
Other Working Capital	67K	2.2M	-296K
Other Non-Cash Items	66K	81K	6.64M
Deferred Income Tax	-2.27M	-890K	23K
Change in Working Capital	67K	2.2M	-296K
Operating Cash Flow	-17.26M	-10.79M	-12.23M
Capital Expenditures	-13.52M	-2.81M	-2.6M
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	-117.01M	-96.89M	-32.85M
Sales Maturities Of Investments	55M	24.41M	41.96M
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	-75.54M	-75.28M	6.5M
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	n/a	-31K	-12K
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	311.55M	-352K	159.68M
Financial Cash Flow	311.55M	-352K	159.68M
Net Cash Flow	218.75M	-86.43M	153.95M
Free Cash Flow	-30.79M	-13.59M	-14.83M